🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CARAMEL Observational Study

Recruitingn/aAges 40 Years - 60 YearsFemaleBiogipuzkoa Health Research Institute
NCT07695376 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

CARAMEL is a project funded by the European Commission under the Horizon Europe programme. Its aim is to develop a personalized prevention approach based on state-of-the-art artificial intelligence models for cardiovascular risk stratification in women aged 40-60 years. These models are trained using large amounts of multi-source data and complemented by digital self-assessment and self-management tools. The CARAMEL consortium brings together a diverse group of 25 organizations, including technology companies and research centers, clinical institutions, as well as experts in ethics, law, and communication. The CARAMEL-OS study is an observational study aimed at prospectively completing the proposed personalized cardiovascular risk stratification model for women aged 40-60 years that will be developed during the earlier phases of the overall CARAMEL project (https://www.caramel-project.e

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women 40 to 60 years of age, at recruitment. * Ability to understand and complete the required informed consent for the study. * Women who are covered by the corresponding healthcare system operating at each clinical site. Exclusion Criteria: * Severe comorbidity with less than 24 months life expectancy. * Lack of basic digital skills to use or carry a smartphone and wearable devices.
💊

What it tests

  • Not listed
📍

Where

6 sites
Keralty SAS
Bogotá, Colombia
Magdalena - Klinika Za Kardiovaskularne Bolesti Medicinskog Fakultetasveucilista J.J. Strossmayera U Osijeku Ustanova
Krapinske Toplice, Croatia
Ethniko Kai Kapodistriako Panepistimio Athinon
Athens, Greece
Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos
Vilnius, Lithuania
Biogipuzkoa Health Research Institute
San Sebastián, Spain
Fundacion Para La Gestion de La Investigacion En Salud de Sevilla
Seville, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy